Home › Drugs by Condition › C › Cough › Guaifenesin/po... Pregnancy Warnings
Print Save or Share

Guaifenesin / potassium guaiacolsulfonate Pregnancy and Breastfeeding Warnings

Guaifenesin / potassium guaiacolsulfonate is also known as: Allfen, Cypex-LA, Humibid LA

Overview

If you become pregnant, discuss with your doctor the benefits and risks of using Guaifenesin/Potassium Guaiacolsulfonate during pregnancy. It is unknown if Guaifenesin/Potassium Guaiacolsulfonate is excreted in breast milk. If you are or will be breast-feeding while you are using Guaifenesin/Potassium Guaiacolsulfonate, check with your doctor or pharmacist to discuss the risks to your baby.

Guaifenesin / potassium guaiacolsulfonate Pregnancy Warnings

Guaifenesin-potassium guaiacolsulfonate has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Guaifenesin-potassium guaiacolsulfonate is only recommended for use during pregnancy when benefit outweighs risk.

Guaifenesin / potassium guaiacolsulfonate Breastfeeding Warnings

There are no data on the excretion of guaifenesin-potassium guaiacolsulfonate into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

(web1)